PINK (Simplify Health Care ETF) Stock Analysis - News

Simplify Health Care ETF (PINK) is a publicly traded the market company. As of May 21, 2026, PINK trades at $35.71 with a market cap of $0 and a P/E ratio of 0.00. PINK moved +0.82% today. Year to date, PINK is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces PINK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in PINK news today?

Biohaven Shares Hit $12.52 Pre-Market After Xenon Trial Shows 42.7% Seizure Drop: Biohaven shares climbed to $12.52 in premarket trading after xenon’s Phase 3 X-TOLE2 study reported a 42.7% median seizure reduction for azetukalner 25 mg. The stock trades 12.5% below its 20-day SMA and has dropped 64.95% over the past year, reflecting ongoing bearish pressure.

PINK Key Metrics

Key financial metrics for PINK
MetricValue
Price$35.71
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume265.36K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PINK News

PINK Analyst Consensus

PINK analyst coverage data. Average price target: $0.00.

Common questions about PINK

What changed in PINK news today?
Biohaven Shares Hit $12.52 Pre-Market After Xenon Trial Shows 42.7% Seizure Drop: Biohaven shares climbed to $12.52 in premarket trading after xenon’s Phase 3 X-TOLE2 study reported a 42.7% median seizure reduction for azetukalner 25 mg. The stock trades 12.5% below its 20-day SMA and has dropped 64.95% over the past year, reflecting ongoing bearish pressure.
Does Rallies summarize PINK news?
Yes. Rallies summarizes PINK news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is PINK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PINK. It does not provide personalized investment advice.
PINK

PINK